A single panel of three sero antigens (CEA, CA125, cytokeratin fragment 21-1) and 1 autoantibody marker (New York esophageal squamous cell carcinoma 1) performed well in the high-risk group, with a sensitivity of 71% and specificity of 88% for lung cancer [112]. Here, CEACAM5 is linked to lung cancer.